Monografie
Up-regulation of Biglycan is associated with poor prognosis and PTEN deletionin patients with prostate cancer
- Sprache
-
Deutsch
- Identifier
-
1181328918
Thema
Prostate--Cancer; Prognosis; Cancer; Prostate; Patients; BGN ; Biglycan ; CHD1 ; Chromodomain-helicase-DNA-binding protein 1 ; ERCC1 ; Excision repair cross-complementation ; ERG
Beteiligte Personen und Organisationen
Kraft, Juliane Viktoria
Windhorst, Sabine
Windhorst, Sabine
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Objekttyp
- Monografie
Beteiligte
- Kraft, Juliane Viktoria
- Windhorst, Sabine
Ähnliche Objekte (12)
Anti-cancer vaccination – Immunomonitoring of a clinical phase I/II study in prostate cancer patients vaccinated with a RhoC-derived synthetic peptide
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
Metabolomic Imaging for Human Prostate Cancer Detection using MR Spectroscopy at 7T
Neuronal autoantibodies associated with memory impairment in prostate cancer patients
Mutations in regulators of the epigenome and their effects on the DNA methylome
Effect of multipeptide vaccination therapy on disease outcome of patients with prostate cancer and biochemical recurrence
Validation of an oxygen-dependent tumour response simulation model in three sublines of a rat prostate carcinoma
Is It Appropriate to Use Only Magnetic Resonance Imaging/transrectal Ultrasound (MRI/TRUS) Fusion Targeted Biopsy for Diagnosis of Prostate Cancer in Patients with Positive mpMRI Results?
Correlation of molecular imaging of PSMA-ligand uptake with clinicohistopathological parameters and biochemical recurrence prediction in primary prostate cancer patients
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Role of RAI2 protein in the progression of prostate and breast cancer
The influence of phytochemicals on cancer stem cells in prostate cancer
Anti-cancer vaccination – Immunomonitoring of a clinical phase I/II study in prostate cancer patients vaccinated with a RhoC-derived synthetic peptide
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
Metabolomic Imaging for Human Prostate Cancer Detection using MR Spectroscopy at 7T
Neuronal autoantibodies associated with memory impairment in prostate cancer patients
Mutations in regulators of the epigenome and their effects on the DNA methylome
Effect of multipeptide vaccination therapy on disease outcome of patients with prostate cancer and biochemical recurrence
Validation of an oxygen-dependent tumour response simulation model in three sublines of a rat prostate carcinoma
Is It Appropriate to Use Only Magnetic Resonance Imaging/transrectal Ultrasound (MRI/TRUS) Fusion Targeted Biopsy for Diagnosis of Prostate Cancer in Patients with Positive mpMRI Results?
Correlation of molecular imaging of PSMA-ligand uptake with clinicohistopathological parameters and biochemical recurrence prediction in primary prostate cancer patients
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Role of RAI2 protein in the progression of prostate and breast cancer
The influence of phytochemicals on cancer stem cells in prostate cancer
Anti-cancer vaccination – Immunomonitoring of a clinical phase I/II study in prostate cancer patients vaccinated with a RhoC-derived synthetic peptide
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
Metabolomic Imaging for Human Prostate Cancer Detection using MR Spectroscopy at 7T
Neuronal autoantibodies associated with memory impairment in prostate cancer patients
Mutations in regulators of the epigenome and their effects on the DNA methylome
Effect of multipeptide vaccination therapy on disease outcome of patients with prostate cancer and biochemical recurrence
Validation of an oxygen-dependent tumour response simulation model in three sublines of a rat prostate carcinoma
Is It Appropriate to Use Only Magnetic Resonance Imaging/transrectal Ultrasound (MRI/TRUS) Fusion Targeted Biopsy for Diagnosis of Prostate Cancer in Patients with Positive mpMRI Results?
Correlation of molecular imaging of PSMA-ligand uptake with clinicohistopathological parameters and biochemical recurrence prediction in primary prostate cancer patients
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Role of RAI2 protein in the progression of prostate and breast cancer